Patents by Inventor John Herrmann

John Herrmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Wireless power transfer using a microwave signal
    Patent number: 9711973
    Abstract: A wireless power source including a microwave receiver, a matching network, and a transducer. The microwave receiver receives a microwave signal having a carrier frequency. The matching network receives a signal having the carrier frequency and a switched frequency and removes the carrier frequency such that the matching network outputs a switched signal at the switched frequency. The transducer is configured to receive the switched signal and output a DC voltage.
    Type: Grant
    Filed: April 24, 2015
    Date of Patent: July 18, 2017
    Assignee: MOTOROLA SOLUTIONS, INC.
    Inventors: David Wallis, John Herrmann
  • Antibodies Directed To GPNMB And Uses Thereof
    Publication number: 20160311919
    Abstract: The present invention provides fully human monoclonal antibodies that specifically bind to GPNMB, and uses thereof. Nucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions and/or complementarity determining regions (CDRs) are provided. The present invention also provides immunoconjugates comprising anti-GPNMB antibodies and methods of using such immunoconjugates. The present invention further provides bi-specific antibodies comprising an anti-GPNMB antibody component and an anti-CD3 component, and methods of using such bispecific antibodies.
    Type: Application
    Filed: February 25, 2016
    Publication date: October 27, 2016
    Inventors: Feng Xiao, Xiao-Chi Jia, Meina Liang, Orit Foord, Scott Klakamp, Kam Fai Tse, Vincent A. Pollack, Luca Rastelli, John Herrmann, Henri Lichenstein, Michael E. Jeffers, William J. LaRochelle, Gulshan Ara, Peter Mezes, Andrei Chapoval, Cyrus Karkaria, Michael Torgov, Juan Davagnino
  • WIRELESS POWER TRANSFER USING A MICROWAVE SIGNAL
    Publication number: 20160315480
    Abstract: A wireless power source including a microwave receiver, a matching network, and a transducer. The microwave receiver receives a microwave signal having a carrier frequency. The matching network receives a signal having the carrier frequency and a switched frequency and removes the carrier frequency such that the matching network outputs a switched signal at the switched frequency. The transducer is configured to receive the switched signal and output a DC voltage.
    Type: Application
    Filed: April 24, 2015
    Publication date: October 27, 2016
    Inventors: David Wallis, John Herrmann
  • Antibodies Directed to GPNMB and Uses Thereof
    Publication number: 20150044212
    Abstract: The present invention provides fully human monoclonal antibodies that specifically bind to GPNMB, and uses thereof. Nucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions and/or complementarity determining regions (CDRs) are provided. The present invention also provides immunoconjugates comprising anti-GPNMB antibodies and methods of using such immunoconjugates. The present invention further provides bi-specific antibodies comprising an anti-GPNMB antibody component and an anti-CD3 component, and methods of using such bispecific antibodies.
    Type: Application
    Filed: August 7, 2014
    Publication date: February 12, 2015
    Inventors: Feng Xiao, Xiao-Chi Jia, Meina Liang, Orit Foord, Scott Klakamp, Kam Fai Tse, Vincent A. Pollack, Luca Rastelli, John Herrmann, Henri Lichenstein, Michael E. Jeffers, William J. LaRochelle, Gulshan Ara, Peter Mezes, Andrei Chapoval, Cyrus Karkaria, Michael Torgov, Juan Davagnino
  • Antibodies directed to GPNMB and uses thereof
    Patent number: 8846873
    Abstract: The present invention provides fully human monoclonal antibodies that specifically bind to GPNMB, and uses thereof. Nucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions and/or complementarity determining regions (CDRs) are provided. The present invention also provides immunoconjugates comprising anti-GPNMB antibodies and methods of using such immunoconjugates. The present invention further provides bi-specific antibodies comprising an anti-GPNMB antibody component and an anti-CD3 component, and methods of using such bispecific antibodies.
    Type: Grant
    Filed: January 20, 2012
    Date of Patent: September 30, 2014
    Assignees: Celldex Therapeutics, Inc., Amgen Fremont, Inc.
    Inventors: Feng Xiao, Xiao-Chi Jia, Meina Liang, Orit Foord, Scott Klakamp, Kam Fai Tse, Vincent A. Pollack, Luca Rastelli, John Herrmann, Henri Lichenstein, Michael Jeffers, William LaRochelle, Gulshan Ara, Peter Mezes, Andrei Chapoval, Cyrus Karkaria, Michael Torgov, Juan Davagnino
  • Connector for connecting building components
    Patent number: 8387321
    Abstract: A connector for a wall structure wherein the connector connects to and reinforces a stud within the wall structure, or in some cases, the connector actually functions as a stud. The connector includes an elongated web and a pair of flanges that project from the web. About the lower portion of the connector there is provided a series of tabs that extend from the web and the two flanges and are turned so as to overlap and form a transfer structure that extends between the flanges about the lower end of the connector. In use, the connector can be connected to respective studs in a wall structure and at the same time anchor to an underlying structure such as a floor. In other cases, the connector itself can be utilized in the wall structure as a stud.
    Type: Grant
    Filed: May 19, 2009
    Date of Patent: March 5, 2013
    Assignee: The Steel Network, Inc.
    Inventors: Edward R. diGirolamo, John Herrmann, Nabil Abdel-Rahman
  • Antibodies Directed To GPNMB And Uses Thereof
    Publication number: 20130022597
    Abstract: The present invention provides fully human monoclonal antibodies that specifically bind to GPNMB, and uses thereof. Nucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions and/or complementarity determining regions (CDRs) are provided. The present invention also provides immunoconjugates comprising anti-GPNMB antibodies and methods of using such immunoconjugates. The present invention further provides bi-specific antibodies comprising an anti-GPNMB antibody component and an anti-CD3 component, and methods of using such bispecific antibodies.
    Type: Application
    Filed: January 20, 2012
    Publication date: January 24, 2013
    Inventors: Meina Liang, Orit Foord, Scott Klakamp, Vincent A. Pollack, Luca Rastelli, John Herrmann, Henri Lichenstein, Michael Jeffers, William LaRochelle, Peter Mezes, Andrei Chapoval, Cyrus Karkaria, Michael Torgov, Juan Davagnino
  • CONNECTOR FOR CONNECTING BUILDING COMPONENTS
    Publication number: 20100126103
    Abstract: A connector for a wall structure wherein the connector connects to and reinforces a stud within the wall structure, or in some cases, the connector actually functions as a stud. The connector includes an elongated web and a pair of flanges that project from the web. About the lower portion of the connector there is provided a series of tabs that extend from the web and the two flanges and are turned so as to overlap and form a transfer structure that extends between the flanges about the lower end of the connector. In use, the connector can be connected to respective studs in a wall structure and at the same time anchor to an underlying structure such as a floor. In other cases, the connector itself can be utilized in the wall structure as a stud.
    Type: Application
    Filed: May 19, 2009
    Publication date: May 27, 2010
    Applicant: THE STEEL NETWORK, INC.
    Inventors: Edward R. diGirolamo, John Herrmann, Nabil Abdel-Rahman
  • Novel proteins and nucleic acids encoding same
    Publication number: 20080171046
    Abstract: Disclosed herein are novel human nucleic acid sequences which encode polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Application
    Filed: May 12, 2004
    Publication date: July 17, 2008
    Inventors: Corine Vermet, Elma Fernandes, Richard Shimkets, John Herrmann, Kumud Majumder, John MacDougall, Vishnu Mishra, Peter S. Mezes, Luca Rastelli
  • Method for analyzing a nucleic acid
    Publication number: 20070178452
    Abstract: Disclosed is a method in which DNA sequences derived from microsome-associated mRNA sequences in a mixed sample or in an arrayed single sequence clone can be determined and classified without sequencing. The methods make use of information on the presence of carefully chosen target subsequences, typically of length from 4 to 8 base pairs, and preferably the length between target subsequences in a sample DNA sequence together with DNA sequence databases containing lists of sequences likely to be present in the sample to determine a sample sequence. The preferred method uses restriction endonucleases to recognize target subsequences and cut the sample sequence. Then carefully chosen recognition moieties are ligated to the cut fragments, the fragments amplified, and the experimental observation made. Polymerase chain reaction (PCR) is the preferred method of amplification.
    Type: Application
    Filed: October 21, 2002
    Publication date: August 2, 2007
    Inventors: Pascal Bouffard, John Herrmann, Chunli Huang, Michael Jeffers, Jingfang Ju, Luca Rastelli, Juliette Shimkets, Jan Simons, Bruce Taillon
  • Proteins and nucleic acids encoding same
    Patent number: 7141549
    Abstract: Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Grant
    Filed: February 8, 2005
    Date of Patent: November 28, 2006
    Inventors: Peter Mezes, Luca Rastelli, John Herrmann, John MacDougall, Haihong Zhong, Stacie Casman, Ferenc Boldog, Richard Shimkets, Linda Gorman, Andrew Eisen, Steven Spaderna, Corine Vernet, Constance Berghs, Kimberly Spytek, Vincent DiPippo, Bryan Zerhusen, John Peyman, Karen Ellerman, David Stone, William Grosse, John Alsobrook, II, Denise Lepley, Daniel Rieger, Catherine Burgess, Shlomit Edinger, Edward Voss, Charles Miller
  • Novel proteins and nucleic acids encoding same
    Publication number: 20060084054
    Abstract: The present invention provides novel isolated polynucleotides and small molecule target polypeptides encoded by the polynucleotides. Antibodies that immunospecifically bind to a novel small molecule target polypeptide or any derivative, variant, mutant or fragment of that polypeptide, polynucleotide or antibody are disclosed, as are methods in which the small molecule target polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states. More specifically, the present invention discloses methods of using recombinantly expressed and/or endogenously expressed proteins in various screening procedures for the purpose of identifying therapeutic antibodies and therapeutic small molecules associated with diseases. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Application
    Filed: June 4, 2003
    Publication date: April 20, 2006
    Inventors: John Alsobrook, David Anderson, Jason Baumgartner, Constance Berghs, Ferenc Boldog, Catherine Burgess, Stacie Casman, Elina Catterton, Mohanraj Dhanabal, Shlomit Edinger, Karen Ellerman, Seth Ettenberg, Esha Gangolli, Valerie Gerlach, Linda Gorman, William Grosse, Erik Gunther, Xiaojia Guo, Vladimir Gusev, John Herrmann, Weizhen Ji, Ramesh Kekuda, Nikolai Khramtsov, William LaRochelle, Li Li, Hongping Liang, Kenneth Low, John MacDougall, Timothy Maclachlan, Uriel Malyankar, Kelly McQueeney, Amanda Mezick, Charles Miller, Isabelle Millet, Muralidhara Padigaru, Meera Patturajan, John Peyman, Xiaozhong Qian, Luca Rastelli, Daniel Rieger, Mark Rothenberg, Suresh Shenoy, Richard Shimkets, Glennda Smithson, Kimberly Spytek, David Stone, Sujatha Sukumaran, Edward Szekeres, Corine Vernet, Edward Voss, Adam Wolenc, Mei Zhong, Haihong Zhong
  • Proteins and nucleic acids encoding same
    Publication number: 20060013813
    Abstract: Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Application
    Filed: February 8, 2005
    Publication date: January 19, 2006
    Inventors: Peter Mezes, Luca Rastelli, John Herrmann, John MacDougall, Haihong Zhong, Stacie Casman, Frenc Boldog, Richard Shimkets, Linda Gorman, Andrew Eisen, Steven Spaderna, Corine Vernet, Constance Berghs, Kimberly Spytek, Vincent DiPippo, Bryan Zerhusen, John Peyman, Karen Ellerman, David Stone, William Grosse, John Alsobrook, Denise Lepley, Daniel Rieger, Catherine Burgess, Sholmit Edinger, Edward Voss, Charles Miller
  • Therapeutic polypeptides, nucleic acids encoding same, and methods of use
    Publication number: 20060003323
    Abstract: Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide. Vectors, host cells, antibodies and recombinant methods for producing the polypeptides and polynucleotides, as well as methods for using same are also included. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Application
    Filed: June 3, 2003
    Publication date: January 5, 2006
    Inventors: John Alsobrook, Enrique Alvarez, David Anderson, Ferenc Boldog, Stacie Casman, Elina Catterton, Andrei Chapoval, Julie Crabtree-Bokor, Shlomit Edinger, Karen Ellerman, Seth Ettenberg, Esha Gangolli, Valerie Gerlach, Linda Gorman, Erik Gunther, Xiaojia (Sasha) Guo, Vladimir Gusev, John Herrmann, Weizhen Ji, Ramesh Kekuda, Li Li, Xiaohong Liu, John MacDougall, Timothy Machlachlan, Uriel Malyankar, Amanda Mezick, Isabelle Millet, Vishnu Mishra, Muralidhara Padigaru, Meera Patturajan, Carol Pena, John Peyman, Debasish Raha, Luca Rastelli, Daniel Rieger, Mark Rothenberg, Paul Sciore, Suresh Shenoy, Richard Shimkets, Glennda Smithson, Kimberly Spytek, David Stone, Corine Vernet, Edward Voss, Mei Zhong, Hiahong Zhong
  • Battery protection circuit
    Publication number: 20050285572
    Abstract: A battery protection circuit is provided that includes current monitoring circuit. The current monitoring circuit senses current flowing to or from a rechargeable cell. When the current exceeds a maximum value, the current monitoring circuit actuates, whereby opening a transistor. The transistor has a resistor couple in parallel. When the transistor opens, current is forced through the resistor coupled in parallel with the transistor, thereby limiting the current to a maximum value. The current monitoring circuit also simulates an overcurrent condition in the safety circuit. The overcurrent condition causes a disconnect switch to open, thereby disconnecting the cell(s) from the external terminals.
    Type: Application
    Filed: June 29, 2004
    Publication date: December 29, 2005
    Inventors: Michael Geren, Jennifer Collier, John Herrmann
  • Cell balancing circuit
    Publication number: 20050269989
    Abstract: A cell balancing circuit monitors the voltage between serially connected cells and compares it to a reference voltage. From that comparison, the cell balancing circuit sources or sinks current into a midpoint node between rechargeable cells to keep the cells balanced during the charging process. In one preferred embodiment, the cell balancing circuit includes an op-amp, connected in a unity gain configuration. A voltage divider establishes a reference voltage equal to the average of the two cell voltages. The op-amp compares this average to the measured voltage at the midpoint node. When the average voltage exceeds the voltage at the midpoint node, the op-amp sources current into the midpoint node. When the average voltage falls below the voltage at the midpoint node, the op-amp sinks current from the midpoint node. By sourcing or sinking current, the cell balancing circuit allows the lesser charged cell to catch up with the more fully charged cell.
    Type: Application
    Filed: June 5, 2004
    Publication date: December 8, 2005
    Inventors: Michael Geren, John Oglesbee, John Herrmann, Stephanie Smith, Roger Boyer
  • Growth factor polypeptides and nucleic acids encoding same
    Publication number: 20050171020
    Abstract: Disclosed are novel nucleic acids encoding proteins and polypeptides related to bone morphogenetic protein-1 (BMF1) and to vascular endothelial growth factor E (VEGF-E).
    Type: Application
    Filed: April 1, 2005
    Publication date: August 4, 2005
    Inventors: Richard Shimkets, Henri Lichenstein, John Herrmann, Ferenc Boldog
  • Novel proteins and nucleic acids encoding same
    Publication number: 20050153305
    Abstract: Disclosed herein are novel human nucleic acid sequences which encode polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Application
    Filed: May 21, 2004
    Publication date: July 14, 2005
    Inventors: Corine Vernet, Catherine Burgess, Elma Fernandes, Raymond Taupier, Kerry Quinn, Kimberly Spytek, Luca Rastelli, John Herrmann
  • POWER FAULT BATTERY PROTECTION CIRCUIT
    Publication number: 20050127878
    Abstract: A battery protection circuit is provided that includes a safety circuit and an overpower circuit. The safety circuit monitors the voltage and current of at least one rechargeable cell within the battery pack, and disconnects the cell(s) from the external terminals of the battery pack when either the voltage becomes too high or low, or when excessive current is being drawn from the battery pack. The overpower circuit monitors the power being delivered to or sourced from the battery pack to the load. The overpower circuit actuates when the power exceeds a predetermined threshold, thereby simulating an overcurrent condition in the safety circuit. The overcurrent condition causes a disconnect means, like a transistor, to open, thereby disconnecting the cell(s) from the external terminals. The battery protection circuit then latches in this disconnected state until a load is removed from the terminals of the battery pack.
    Type: Application
    Filed: December 16, 2003
    Publication date: June 16, 2005
    Inventors: Michael Geren, Roger Boyer, John Herrmann, Jenny Collier
  • Antibodies to fibroblast growth factor and their methods of use
    Publication number: 20050063971
    Abstract: The present invention provides FGF-CX, a novel isolated polypeptide, as well as a polynucleotide encoding FGF-CX and antibodies that immunospecifically bind to FGF-CX or any derivative, variant, mutant, or fragment of the FGF-CX polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the FGF-CX polypeptide, polynucleotide and antibody are used in detection and treatment of a broad range of pathological states, as well as other uses.
    Type: Application
    Filed: September 23, 2004
    Publication date: March 24, 2005
    Inventors: Michael Jeffers, Richard Shimkets, Sudhirdas Prayaga, Ferenc Boldog, Meijia Yang, Catherine Burgess, Elma Fernandes, John Herrmann, William LaRochelle, Henri Lichenstein